‘Pharmacy-mediated substitution is defined as a framework permitting substitution of biotherapeutics at the pharmacy level without the consent of the prescribing physician. IFPMA believes there should be a distinction in public health policy between this type of substitution and the type of switching performed under medical supervision. The following policy position developed by IFPMA is...
Read morePsoriasis was recognized for the first time as a serious non-communicable disease at the World Health Assembly in 2014. To help bring the public health impact of psoriasis into focus and to help raise awareness of the range of ways that psoriasis can affect peoples’ lives, IFPMA presents the recommendations from the WHO Global report...
Read moreABPI, EFPIA and IFPMA issue joint statement following publication of the final report by the Review on AMR The Association of the British Pharmaceutical Industry (ABPI), the European Federation of Pharmaceutical Industries and Associations (EFPIA) and the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) have today issued a joint statement following the publication of...
Read moreBrazzaville/Kigali, 11 May 2016 – Ongoing efforts to prevent and control cervical cancer in the African Region have received a significant boost following the announcement of a pioneering partnership between the World Health Organization African Region (WHO AFRO) and the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA). The new partnership, “AFRO Comprehensive Cervical...
Read moreWatch what healthcare stakeholders and regulatory experts are saying today about the opportunities & challenges facing biotherapeutic medicines. On more details of this event, click here: http://ifpma.org/events-2/biotherapeutic-medicines-a-winning-formula-for-patients/
Read moreViral hepatitis – a silent, but preventable epidemic Recent breakthroughs in available treatment options and the broader objectives of the health-related Sustainable Development Goals (SGDs) make the WHO target of eliminating viral hepatitis by 2030 feasible. Earlier this week, the WHO issued updated guidelines for the treatment of hepatitis C infection, to “promote the transition...
Read moreIt seems there is always a new story in the media about an emerging health threat. Right now, understandably, there is significant public concern about the spread of the Zika virus.
Read more